Mbx Biosciences Common Stock Price Prediction
| MBX Stock | 29.03 0.00 0.00% |
Momentum 57
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.66) | EPS Estimate Current Year (2.54) | EPS Estimate Next Year (3.19) | Wall Street Target Price 59.25 | EPS Estimate Current Quarter (0.66) |
Using MBX Biosciences hype-based prediction, you can estimate the value of MBX Biosciences Common from the perspective of MBX Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards MBX Biosciences using MBX Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards MBX using crowd psychology based on the activity and movement of MBX Biosciences' stock price.
MBX Biosciences Short Interest
An investor who is long MBX Biosciences may also wish to track short interest. As short interest increases, investors should be becoming more worried about MBX Biosciences and may potentially protect profits, hedge MBX Biosciences with its derivative instruments, or be ready for some potential downside.
200 Day MA 15.7063 | Short Percent 0.1285 | Short Ratio 4.86 | Shares Short Prior Month 4.1 M | 50 Day MA 27.0986 |
MBX Biosciences Common Hype to Price Pattern
Investor biases related to MBX Biosciences' public news can be used to forecast risks associated with an investment in MBX. The trend in average sentiment can be used to explain how an investor holding MBX can time the market purely based on public headlines and social activities around MBX Biosciences Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of MBX Biosciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about MBX Biosciences.
MBX Biosciences Implied Volatility | 1.96 |
MBX Biosciences' implied volatility exposes the market's sentiment of MBX Biosciences Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if MBX Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that MBX Biosciences stock will not fluctuate a lot when MBX Biosciences' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in MBX Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying MBX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MBX Biosciences after-hype prediction price | USD 32.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current MBX contract
Based on the Rule 16, the options market is currently suggesting that MBX Biosciences Common will have an average daily up or down price movement of about 0.12% per day over the life of the 2026-03-20 option contract. With MBX Biosciences trading at USD 29.03, that is roughly USD 0.0356 . If you think that the market is fully incorporating MBX Biosciences' daily price movement you should consider acquiring MBX Biosciences Common options at the current volatility level of 1.96%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out MBX Biosciences Basic Forecasting Models to cross-verify your projections. MBX Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of MBX Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MBX Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MBX Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MBX Biosciences Estimiated After-Hype Price Volatility
In the context of predicting MBX Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MBX Biosciences' historical news coverage. MBX Biosciences' after-hype downside and upside margins for the prediction period are 27.04 and 37.64, respectively. We have considered MBX Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MBX Biosciences is not too volatile at this time. Analysis and calculation of next after-hype price of MBX Biosciences Common is based on 3 months time horizon.
MBX Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as MBX Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MBX Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MBX Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.18 | 5.26 | 1.76 | 0.09 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
29.03 | 32.34 | 5.86 |
|
MBX Biosciences Hype Timeline
On the 5th of January MBX Biosciences Common is traded for 29.03. The entity has historical hype elasticity of 1.76, and average elasticity to hype of competition of 0.09. MBX is forecasted to increase in value after the next headline, with the price projected to jump to 32.34 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 5.86%, whereas the daily expected return is now at 1.18%. The volatility of related hype on MBX Biosciences is about 6921.05%, with the expected price after the next announcement by competition of 29.12. MBX Biosciences generates negative cash flow from operationsConsidering the 90-day investment horizon the next forecasted press release will be in about 7 days. Check out MBX Biosciences Basic Forecasting Models to cross-verify your projections.MBX Biosciences Related Hype Analysis
Having access to credible news sources related to MBX Biosciences' direct competition is more important than ever and may enhance your ability to predict MBX Biosciences' future price movements. Getting to know how MBX Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MBX Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MGTX | MeiraGTx Holdings PLC | (0.26) | 9 per month | 0.00 | (0.02) | 6.05 | (5.54) | 18.08 | |
| REPL | Replimune Group | 0.34 | 9 per month | 2.63 | 0.13 | 8.97 | (4.66) | 108.39 | |
| AVBP | ArriVent BioPharma Common | (0.17) | 3 per month | 2.97 | 0.05 | 6.31 | (4.98) | 15.68 | |
| DNA | Ginkgo Bioworks Holdings | 0.12 | 10 per month | 0.00 | (0.13) | 8.52 | (9.38) | 33.15 | |
| IOVA | Iovance Biotherapeutics | 0.07 | 9 per month | 3.89 | 0.05 | 11.81 | (7.38) | 37.34 | |
| MLTX | MoonLake Immunotherapeutics | (0.37) | 8 per month | 3.45 | 0.18 | 8.68 | (5.16) | 22.06 | |
| ATXS | Astria Therapeutics | (0.06) | 7 per month | 0.00 | 0.18 | 3.57 | (1.79) | 38.97 | |
| ERAS | Erasca Inc | 0.12 | 5 per month | 3.02 | 0.18 | 11.24 | (4.72) | 20.96 | |
| RGNX | Regenxbio | 1.22 | 9 per month | 3.46 | 0.12 | 8.56 | (6.11) | 26.54 | |
| VSTM | Verastem | (0.25) | 12 per month | 0.00 | (0.04) | 5.83 | (7.25) | 29.79 |
MBX Biosciences Additional Predictive Modules
Most predictive techniques to examine MBX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MBX using various technical indicators. When you analyze MBX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MBX Biosciences Predictive Indicators
The successful prediction of MBX Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MBX Biosciences Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MBX Biosciences based on analysis of MBX Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MBX Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MBX Biosciences's related companies. | 2023 | 2024 | 2025 (projected) | Current Ratio | 21.26 | 24.19 | 21.77 | Net Debt To EBITDA | 0.86 | 0.72 | 0.83 |
Story Coverage note for MBX Biosciences
The number of cover stories for MBX Biosciences depends on current market conditions and MBX Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MBX Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MBX Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
MBX Biosciences Short Properties
MBX Biosciences' future price predictability will typically decrease when MBX Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MBX Biosciences Common often depends not only on the future outlook of the potential MBX Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MBX Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.4 M | |
| Cash And Short Term Investments | 262.1 M |
Additional Tools for MBX Stock Analysis
When running MBX Biosciences' price analysis, check to measure MBX Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences is operating at the current time. Most of MBX Biosciences' value examination focuses on studying past and present price action to predict the probability of MBX Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences' price. Additionally, you may evaluate how the addition of MBX Biosciences to your portfolios can decrease your overall portfolio volatility.